Gly-Pro-Glu is a peptide compound extensively utilized in the biomedical industry. This product exhibits potential inhibitory effects on neovascularization, thereby aiding in the prevention and management of this debilitating condition.
CAT No: R1990
CAS No:32302-76-4
Synonyms/Alias:Gly-pro-glu;Glycyl-prolyl-glutamic acid;32302-76-4;Glypromate;ZYK4RVV5LS;glycyl-l-prolyl-l-glutamic acid;(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]pentanedioic acid;IGF-I (1-3);L-Glutamic acid, glycyl-L-prolyl-;(1-3)IGF-1;(1-3)-HUMAN INSULIN-LIKE GROWTH FACTOR I;MFCD00144405;UNII-ZYK4RVV5LS;CHEMBL371315;SCHEMBL1170125;DTXSID80186038;CHEBI:163960;H-Gly-Pro-Glu-OH; H-GPE-OH;Gly-Pro-Glu, >=98% (HPLC);DB05633;DA-53632;FI108678;HY-117483;L-Glutamic acid, N-(1-glycyl-L-prolyl)-;CS-0066182;NS00069173;BRD-K83502127-001-01-6;
Chemical Name:(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]pentanedioic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.